SKINDERMA Argireline Ampoules – Neuro-Relaxing Peptide Anti-Wrinkle Microneedling Mesotherapy 20 x 2ml

SKINDERMA Argireline 20 x 2ml is a professional mesotherapy solution featuring Argireline (Acetyl Hexapeptide-3) and Leuphasil (Pentapeptide-18) — two complementary neuro-relaxing peptides that work through distinct but synergistic mechanisms to visibly soften expression lines and prevent new wrinkles from forming. This dual-peptide formula delivers one of the most comprehensive neuromodulating protocols available to aesthetic practitioners.

Key Benefits

• Visibly reduces expression lines and dynamic wrinkles
• Dual neuro-relaxing peptide action via two independent pathways
• Prevents formation of new expression lines
• Smooths and refines skin texture on face and neck
• Non-invasive alternative to neurotoxin wrinkle treatments

Active Ingredients

• Argireline — Acetyl Hexapeptide-3 (Acetyl Hexapeptide-8) — the most extensively researched neuromodulating peptide in aesthetic medicine. Argireline is a synthetic hexapeptide that structurally mimics the N-terminal domain of SNAP-25, one of the three proteins that form the SNARE complex — the molecular machine responsible for docking and fusing acetylcholine-containing vesicles with the presynaptic membrane of motor neurons. By competitively binding to the SNARE complex assembly site, Argireline prevents the complete formation of the SNARE complex, inhibiting the calcium-triggered exocytosis of acetylcholine vesicles. The result is a dose-dependent reduction in acetylcholine release at the neuromuscular junction — reducing the frequency and intensity of repetitive facial muscle contractions (such as squinting, frowning, and smiling) that create and deepen expression lines over time. Unlike neuromodulator treatments that irreversibly cleave and permanently inactivate SNAP-25, Argireline acts competitively and reversibly — allowing safe, repeated use in mesotherapy protocols with no risk of permanent muscle paralysis. The wrinkle-softening effect builds progressively over a course of treatments and is particularly pronounced in the forehead, glabellar (frown), periocular (crow’s feet), and perioral regions.
• Leuphasil — Pentapeptide-18 — a synthetic enkephalin analog (a class of endogenous opioid peptides) that acts through a completely different neuromodulatory pathway from Argireline. Leuphasil binds to opioid receptors at the presynaptic membrane, activating G-protein coupled inhibitory signaling (Gi/Go) that reduces intracellular cAMP levels and inhibits voltage-gated calcium channels. The net effect is a reduction in calcium influx into the motor neuron terminal — independently decreasing acetylcholine vesicle exocytosis through the opioid receptor pathway rather than SNARE complex competition. This dual-pathway approach — Argireline targeting SNARE assembly, Leuphasil targeting calcium channel-mediated vesicle release — produces a synergistic inhibition of neuromuscular transmission that is greater than either peptide alone, making the combination formula significantly more effective for expression line reduction than single-peptide protocols.

Treatment Area: Face & Neck
Recommended For: Expression lines, dynamic wrinkles, anti-aging neuro-relaxing peptide protocols
Presentation: 20 x 2ml ampoules

What is Argireline and how does it reduce expression lines? Argireline (Acetyl Hexapeptide-3) mimics the N-terminal domain of SNAP-25 — a key protein in the SNARE complex that controls acetylcholine release at the neuromuscular junction. By competitively binding to the SNARE complex, Argireline inhibits the vesicle fusion that releases acetylcholine, reducing the muscle contraction signals that create and deepen expression lines. The effect is reversible and builds progressively over mesotherapy sessions — making it a safe, non-invasive alternative for practitioners and patients seeking needle-free neuromodulation.

What is Leuphasil and how does it differ from Argireline? Leuphasil (Pentapeptide-18) is a synthetic enkephalin analog that acts on opioid receptors at the presynaptic motor neuron membrane, activating inhibitory G-protein signaling (Gi/Go) that reduces intracellular cAMP and inhibits voltage-gated calcium channels — independently decreasing calcium-triggered acetylcholine release. While Argireline blocks SNARE complex assembly downstream of calcium influx, Leuphasil reduces calcium influx itself — the two peptides act on different points in the neurotransmission cascade, producing a synergistic inhibitory effect on muscle contraction that exceeds what either peptide achieves alone.

How does the dual-peptide formula compare to single neuromodulating peptide protocols? Single-peptide protocols target only one point in the neurotransmission pathway. SKINDERMA Argireline’s dual formula targets two independent mechanisms simultaneously — Argireline at the SNARE complex level and Leuphasil at the calcium channel level — producing a synergistic reduction in acetylcholine release that is greater than either peptide alone. This makes the combination protocol more effective for progressive expression line reduction across a course of mesotherapy sessions.

Who is this product for? SKINDERMA Argireline is formulated for licensed aesthetic practitioners, dermatologists, and skin clinics performing professional anti-wrinkle and neuro-relaxing peptide mesotherapy and microneedling protocols. It is intended for professional clinic use only.

For professional use only. Not intended to diagnose, treat, cure, or prevent any disease.